Trials / Completed
CompletedNCT00842699
Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of the study is to find out the effects of two different drugs used at the beginning of organ transplantation on different populations of immune cells in the body of patients.
Conditions
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2010-09-01
- Completion
- 2011-03-01
- First posted
- 2009-02-12
- Last updated
- 2011-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00842699. Inclusion in this directory is not an endorsement.